Analysis of the UALCAN dataset [9] revealed that CHRM1 transcript levels were approximately 30% lower in colon cancer compared to a normal colon [0.316 versus 1.03 transcripts per million, respectively (p = 0.044)] (Figure 1A). Here, CHRM1 is linked to malignant colon neoplasm.